Abstract Purpose of Review Certain immunocompromised individuals are at risk for
protracted COVID-19, in which SARS-CoV-2 leads to a chronic viral infection. However, the …

Abstract SARS-CoV-2, the agent of the COVID-19 pandemic, emerged in late 2019 in China,
and rapidly spread throughout the world to reach all continents. As the virus expanded in its …

Purpose SARS-CoV-2 infection in immunocompromised hosts is challenging, and
prolonged viral shedding can be a common complication in these patients. We describe the …

We describe the case of a patient with AIDS who had persistent infection with a severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant for> 80 days. The variant …

The presence of anti-IFN neutralizing antibodies (NAB) has been reported in critically ill
COVID-19 patients. We found that 87.5%(7/8) of HIV-1 patients co-infected with SARS-CoV …

Interventions–Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration 111
http://www. cochranehandbook. org.]. The Cochrane'Risk of bias' tool for RCTs addresses …

Aufgrund gleicher Transmissionswege kommen HIV/HCV-Doppelinfektionen häufig vor. In
Deutschland sind etwa 10.000 (15% aller Menschen mit HIV), in den USA 240.000 …

ÖZET Özellikle kronik hastalığı olan koronavirüs hastalığı-2019 (COVID-19) hastalarının
iyileşme süreleri uzayabilmekte ve hastalığın klinik seyri ağır seyredebilmektedir. Uzamış …